Momelotinib dihydrochloride monohydrate

Momelotinib Dihydrochloride Monohydrate is the monohydrate dihydrochloride salt form of momelotinib, an orally bioavailable small molecule inhibitor of wild-type (WT) Janus kinases 1 and 2 (JAK1/2), the JAK2 mutant form JAK2V617F, and activin A receptor type 1 (ACVR1; activin receptor like kinase 2; ALK2), with antineoplastic activity. It is grouped under the following drug class(es): Antineoplastic agents and JAK inhibitors. Its therapeutic use is listed as antineoplastics. The directory classifies it as a commercial API with a synthetic source/manufacturing origin. Other names for this substance include Momelotinib Hydrochloride Hydrate. Its PubChem CID is 102514733.

CAS No 1841094-17-4
Molecular Formula C23H26Cl2N6O3
Molecular Weight 505.4 g/mol
Synonyms N-(cyanomethyl)-4-[2-(4-morpholin-4-ylanilino)pyrimidin-4-yl]benzamide;hydrate;dihydrochloride

Frequently Asked Questions